Skip to content
Review Open access

Fidelity and Delivery: Coupled Barriers in Plant CRISPR-Cas Genome Editing

Aug 2026 · Plant Innovation Journal · 0 citations · 29 references

TL;DR

This review proposes that these constraints are functionally coupled through the intracellular abundance, nuclear access, and chromatin residence time of active Cas-gRNA complexes, which could lead to convergent biochemical solutions spanning herbaceous and woody species.

Abstract

CRISPR-Cas platforms have transformed plant functional genomics, yet nucleases such as Cas9 and Cas12a remain constrained by two seemingly distinct limitations: imperfect target discrimination and inefficient intracellular delivery. Here, this review proposes that these constraints are functionally coupled through the intracellular abundance, nuclear access, and chromatin residence time of active Cas-gRNA complexes. Off-target activity arises from guide-target mismatch tolerance during R-loop formation, whereas rigid plant cell walls constrain the delivery of RNP and DNA cargo. These processes can become coupled when delivery limitations alter the concentration or duration of active Cas-gRNA exposure. When inefficient delivery is addressed through sustained or elevated nuclease expression, it can increase cumulative active Cas-gRNA exposure and may consequently increase off-target risk. Evidence from maize, rice, wheat, and carrot systems is synthesized and convergent biochemical solutions, including transgene-free RNP delivery, are outlined spanning herbaceous and woody species.

Read PDF

Similar papers

Open access Jul 2026

Cas-regulation-targeting chimera enables selective and tunable control of CRISPR/Cas12a

Abstract Selective and tunable regulation of clustered regularly interspaced short palindromic repeats (CRISPR)/Cas12a activity enables on-demand control, yet current strategies remain hindered by nonspecific regulation and limited tunability. Inspired by proximity effect, we present a Cas-regulation-targeting chimera...

Yueyuan Li, Ping Han, Ruo Yuan et al. · 0 citations
Review Open access Jul 2026

Strategies and mechanisms of precision genome engineering: From gene editing to genome writing

Genomic manipulation has advanced from stochastic nuclease‐mediated disruption toward programmable, deterministic precision. Early clustered regularly interspaced short palindromic repeats (CRISPR) strategies enabled targeted mutagenesis through double‐strand breaks; however, their therapeutic application is limited by...

Ke-Rui Huang, Jianhong Tian, Wen-Yan Zhao et al. · 3 citations
Review Aug 2026

Engineering DNA-Targeting CRISPR and CRISPR-Like Effectors: Advances from Rational Design and High-Throughput Screening to AI-Driven Development

Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins constitute adaptive immune systems in prokaryotes and have transformed life sciences, precision medicine, and synthetic biology as programmable genome-editing tools. Despite their broad utility, naturally occurring...

Lingwei She, Zeyu Liang, Qin Zou et al. · 2 citations
Review Open access Aug 2026

Therapeutic CRISPR/Cas9 delivery approaches: strengths, limitations, and a roadmap for clinical translation

A major focus of this review is the inclusion of recent hybrid systems (VLPs, SORT-LNPs) and the recognition that chemical modification of guide RNAs is a critical parameter for therapeutic success and that hybrid systems and stimuli-responsive nanoparticles are poised to dominate the next 5 years of clinical developme...

M. Rezaee, F. Izadi, Saeed Nobaharian et al. · 0 citations
Review 2026

Current advances in mammalian genome modification technology using the CRISPR-Cas9 principle

This article synthesizes contemporary advancements in CRISPR-mediated mammalian genome modification, detailing core mechanisms – such as guide RNA and the Cas9 endonuclease – alongside next-generation modalities, including base and prime editing.

Olga Aldoshina, Dmitriy Lazarev, E. Smirnova · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.